Skip to main content
Clinical Trials/NCT06525402
NCT06525402
Recruiting
Not Applicable

The Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on The Degree of Oral Mucositis in Children Receiving Chemotherapy: A Randomized Controlled Trial

Burdur Mehmet Akif Ersoy University1 site in 1 country54 target enrollmentJanuary 30, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oral Mucositis
Sponsor
Burdur Mehmet Akif Ersoy University
Enrollment
54
Locations
1
Primary Endpoint
Children's International Mucositis Evaluation Scale
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study was planned as a randomized controlled experimental study in order to compare the effects of oral care with saline and black mulberry syrup in addition to sodium bicarbonate on oral mucositis level in children aged 6-18 years receiving chemotherapy.

Detailed Description

Oral mucositis, also known as stomatitis, is the most common complication of cancer treatment. Mucositis affects the patient's nutrition, daily functions, and quality of life, may compromise the ability to tolerate scheduled therapy. For this reason, the children to be included in the study will be randomly divided into three groups. Sodium bicarbonate, which is the routine care in the clinic, will be administered to the control group, and to the intervention groups, saline in addition to the routine care and black mulberry syrup will be applied in addition to the routine care. Data will be collected according to Patient Information Form, International Child Mucositis Assessment Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts. Oral care will be applied to the groups 4 times a day for 14 days. The International Child Mucositis Rating Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts will be evaluated by the researchers on the 1st, 2nd, 4th, 8th and 16th days.

Registry
clinicaltrials.gov
Start Date
January 30, 2025
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Burdur Mehmet Akif Ersoy University
Responsible Party
Principal Investigator
Principal Investigator

Selda Ateş Beşirik

Assistant Professor

Burdur Mehmet Akif Ersoy University

Eligibility Criteria

Inclusion Criteria

  • The willingness of the family and the child to participate in the study
  • Parent and child have separately informed written consent form
  • Be between 6-18 years old
  • Receiving chemotherapy and being hospitalized for chemotherapy treatment
  • Being fed orally

Exclusion Criteria

  • Oral mucositis in the first intraoral evaluation
  • Having diabetes
  • Receiving radiotherapy
  • Having a surgical procedure in the mouth and jaw area
  • Receiving steroid therapy during chemotherapy treatment
  • Using a method other than the methods used in the study to protect the oral mucous membrane throughout the study

Outcomes

Primary Outcomes

Children's International Mucositis Evaluation Scale

Time Frame: up to 16 days

Tomlison et al. (2010) developed Children's International Mucositis Evaluation Scale (ChIMES) in order to evaluate the difficulty experienced by children with cancer due to mouth/throat pain developing depending on mucositis. Yavuz et al., (2011) conducted the validity and reliability study of the Turkish version of the scale. The scale consists of six (6) questions and it is an easy-to-apply form that can be answered with the child's facial expressions.

Oral Mucositis Evaluation Index of the World Health Organization

Time Frame: up to 16 days

It is scored between zero and four points. Although there is no change in the grade-0 mucosa, grade-1 painless ulcers, erythema or mild sensitivity, grade-2 painful erythema and ulcers, solid foods can be consumed. Grade-3 painful erythema, edema or ulcer can be consumed only, grade-4 ulceration, necrosis and hemorrhage are present, the patient cannot be fed, enteral or parenteral support is required.

Secondary Outcomes

  • Neutrophil count(up to 16 days)

Study Sites (1)

Loading locations...

Similar Trials